2D vs 3D Mammography?
The Case for Tomosynthesis


Magnetic Resonance Imaging (MRI) has long been the preferred tool for women who are considered high-risk and have dense breast tissue, to supplement their mammogram. Digital Breast Tomosynthesis (DBT), a 3-D breast imaging technology, has recently gained in popularity as a supplement to mammography in more difficult cases but many physicians have questions about its value versus cost. This free Webinar covers a comparison of 2D vs 3D Mammography, a review of Digital Breast Tomosynthesis, equipment cost considerations, as well as technical requirements to consider before making a switch.   

Watch the webinar to learn:

  • What are the benefits of 2D vs 3D Mammography?

  • How much does implementing tomosynthesis cost?

  • Can my current PACS handle the large file sizes of 3D images?


Join Purview and Dr. Mark Baganz, the Medical Director of Chesapeake Medical Imaging, for an exclusive webinar as we discuss CMI's experiences with their new tomosynthesis imaging equipment.


Phil Jackson, Purview

2d vs 3d mammography

Dr. Mark Baganz, CMI 
Medical Director 


Les Trachtman, Purview
Managing Director 

Phil Jackson is the founder of Purview and oversees technology innovation and evolution. Phil is the author of Purview ViVA, a cloud-based platform that enables anywhere, anytime access to medical imaging data. Prior to founding Purview, Jackson  worked for 10 years as the Chief Technology Officer for Chesapeake Medical Imaging in Annapolis, Maryland.  At Chesapeake Medical Imaging, Phil developed an entire suite of radiology workflow solutions on the Apple platform.  Phil has presented on numerous radiology workflow topics at the Radiology Society of North America's annual conference and is a recognized expert in open source medical imaging technologies. Phil has a Bachelors of Science in Security and Criminal Justice from Northeastern University in Boston, Massachusetts and lives on the Eastern Shore of Maryland with his wife, Emily, and their four children.


Dr. Baganz is the Medical Director of Chesapeake Medical Imaging. A board certified Radiologist, Dr. Baganz completed his fellowship training in Neuroradiology at the University of Maryland in 1994. An expert subspecialist in both neuroradiology and musculoskeletal radiology, Dr. Baganz earned his medical degree from the Howard University College of Medicine and was awarded several academic honors. He served as Director of Neuroradiology, was Assistant Professor of Radiology and Neurology, and was Radiology Residency Program Associate Director from 1994-2001. Dr. Baganz maintains many professional memberships, including the American Society of Neuroradiology (Senior Member), American College of Radiology, American Society of Pediatric Neuroradiology and American Society of Spine Radiology.


Les Trachtman is Managing Director of Purview, a company focused on disrupting the business of medical imaging. Prior to Purview, Les served as CEO of Force 3, Inc., a technology solutions and network security provider.  Over the years, Les has also led other technology companies including Active Endpoints, e-OneHundred, Transcentive, and Metaserver. In his earlier career, Trachtman was responsible for creating the corporate development functions for both Progress Software (PRGS) and Hyperion Solutions (now part of Oracle). Les serves on the board of directors of The Metro Group and as the Entrepreneur in Residence at Union College. Les received a BS in Electrical Engineering from Union College and a JD and MBA from Emory University. Les lives with his wife Michelle on the Severn River in Maryland and is currently authoring a book focused on helping founders transition to professional management.